Khammas, I. et al. 2025. Serum Levels of Advanced Oxidation Protein Products and some Liver Function Markers in Chronic Myeloid Leukemia-Chronic Phase Patients Receiving Imatinib or Nilotinib. Iraqi Journal of Pharmaceutical Sciences . 34, 2 (Jun. 2025), 40–46. DOI:https://doi.org/10.31351/vol34iss2pp40-46.